Shi et al. [17] found that miR-34a targeted and reduced the stability of LINC00473 in cervical cancer, leading to the degradation of oncogene interleukin enhancer binding factor 2 (ILF2) and tumor inhibition. This evidence concerns the gene ILF2 and cervical carcinoma.